MEI Pharma (NASDAQ:MEIP) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note issued to investors on Friday. The firm issued a buy rating on the stock. A number of other research firms have also issued reports on MEIP. TheStreet lowered shares of MEI Pharma from a c- rating to a d+ […]
More Stories
US Trade Deficit Falls to 5-Month Low as Exports Rise to Record High
By Tom Ozimek The U.S. trade deficit narrowed sharply in August to its lowest level in five months, as exports...
Schizophrenia Drug Linked to Pneumonia, Gut Disorders in 25-Year Follow-Up Study
By Huey Freeman Recent research has linked clozapine, a powerful medication for schizophrenia, to an increased risk of mortality associated...
7 Michiganders Charged With Election Fraud in Double-Voting Scheme
By Steven Kovac Four Macomb County, Michigan, voters have been indicted for allegedly voting twice in the Aug. 6 primary,...
From Hawaii to Florida, Tracing Ryan Routh’s Path to Attempted Trump Assassination
By Janice Hisle, Savannah Hulsey Pointer and Arjun Singh KAAAWA, HAWAII, and GREENSBORO, N.C.—Mysteries enshroud Ryan Routh, the 58-year-old man...
Toyota Rolls Back DEI, Prioritizes Employees’ Professional Development
By Tom Ozimek Toyota Motor Corp. has announced significant changes to its “diversity, equity, and inclusion” (DEI) initiatives, halting sponsorship...
FEMA Director: We Have Enough Money for Hurricane Milton, Not Rest of Year
By Jack Phillips The director of the Federal Emergency Management Agency (FEMA) said the agency has enough resources to deal...